YY1 and neoplasm: A study conducted by Pothoulakis and colleagues [82] on colorectal cancer (CRC) patients revealed that upregulation of YY1 resulted in the repression of host immunosurveillance mechanisms through Fas downregulation on tumor cells, and that mRNA expression levels of YY1 and Fas were inversely correlated.